The DOI matches its Crossref record; 321 of the 321 references it cites were found in a registry or an index.
TRAF molecules in cell signaling and in human diseases
Open accessAbstract
The tumor necrosis factor receptor (TNF-R)-associated factor (TRAF) family of intracellular proteins were originally identified as signaling adaptors that bind directly to the cytoplasmic regions of receptors of the TNF-R superfamily. The past decade has witnessed rapid expansion of receptor families identified to employ TRAFs for signaling. These include Toll-like receptors (TLRs), NOD-like receptors (NLRs), RIG-I-like receptors (RLRs), T cell receptor, IL-1 receptor family, IL-17 receptors, IFN receptors and TGFβ receptors. In addition to their role as adaptor proteins, most TRAFs also act as E3 ubiquitin ligases to activate downstream signaling events. TRAF-dependent signaling pathways typically lead to the activation of nuclear factor-κBs (NF-κBs), mitogen-activated protein kinases (MAPKs), or interferon-regulatory factors (IRFs). Compelling evidence obtained from germ-line and cell-specific TRAF-deficient mice demonstrates that each TRAF plays indispensable and non-redundant physiological roles, regulating innate and adaptive immunity, embryonic development, tissue homeostasis, stress response, and bone metabolism. Notably, mounting evidence implicates TRAFs in the pathogenesis of human diseases such as cancers and autoimmune diseases, which has sparked new appreciation and interest in TRAF research. This review presents an overview of the current knowledge of TRAFs, with an emphasis on recent findings concerning TRAF molecules in signaling and in human diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304
The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling
O'Neill, L. A. J., & Bowie, A. G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2079 · Cited by 2,667
Immune Signaling by RIG-I-like Receptors
Loo, Y.-M., & Gale, M. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.003 · Cited by 1,875 · cited 16×
“The NEMO-like adaptor proteins TANK, NAP1, and SINTBAD are constitutively bound to both TBK1 and IKKε [135].”
BackgroundInfluentialTlr signalling augments macrophage bactericidal activity through mitochondrial ros
West, A. P., Brodsky, I. E., Rahner, C., Woo, D. K., Erdjument-Bromage, H., Tempst, P., Walsh, M. C., Choi, Y., Shadel, G. S., & Ghosh, S. (2011) · Nature · doi:10.1038/nature09973 · Cited by 1,659
Enhancing CD8 T-cell memory by modulating fatty acid metabolism
Pearce, E. L., Walsh, M. C., Cejas, P. J., Harms, G. M., Shen, H., Wang, L.-S., Jones, R. G., & Choi, Y. (2009) · Nature · doi:10.1038/nature08097 · Cited by 1,559
Structure and signalling in the IL-17 receptor family
Gaffen, S. L. (2009) · Nature reviews. Immunology · doi:10.1038/nri2586 · Cited by 1,475
Failure to Regulate TNF-Induced NF-κB and Cell Death Responses in A20-Deficient Mice
Lee, E. G., Boone, D. L., Chai, S., Libby, S. L., Chien, M., Lodolce, J. P., & Ma, A. (2000) · Science · doi:10.1126/science.289.5488.2350 · Cited by 1,409 · cited 1×
“Notably, A20 −/− and MCPIP1 −/− mice spontaneously develop severe inflammatory syndrome [219, 220] , while CYLD −/− and Usp25 −/− mice are more susceptible to inflammation [204, 221] .”
BackgroundTRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
Lomaga, M. A., Yeh, W.-C., Sarosi, I., Duncan, G. S., Furlonger, C., Ho, A., Morony, S., Capparelli, C., Van, G., Kaufman, S., et al. (1999) · Genes & Development · doi:10.1101/gad.13.8.1015 · Cited by 1,267
IAP Antagonists Induce Autoubiquitination of c-IAPs, NF-κB Activation, and TNFα-Dependent Apoptosis
Varfolomeev, E., Blankenship, J. W., Wayson, S. M., Fedorova, A. V., Kayagaki, N., Garg, P., Zobel, K., Dynek, J. N., Elliott, L. O., Wallweber, H. J. A., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.030 · Cited by 1,218
The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses
Boone, D. L., Turer, E. E., Lee, E. G., Ahmad, R.-C., Wheeler, M. T., Tsui, C., Hurley, P., Chien, M., Chai, S., Hitotsumatsu, O., et al. (2004) · Nature Immunology · doi:10.1038/ni1110 · Cited by 1,090
IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosis
Vince, J. E., Wong, W. W.-L., Khan, N., Feltham, R., Chau, D., Ahmed, A. U., Benetatos, C. A., Chunduru, S. K., Condon, S. M., McKinlay, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.037 · Cited by 1,053
Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma
Compagno, M., Lim, W. K., Grunn, A., Nandula, S. V., Brahmachary, M., Shen, Q., Bertoni, F., Ponzoni, M., Scandurra, M., Califano, A., et al. (2009) · Nature · doi:10.1038/nature07968 · Cited by 1,038
Kawai, T., Sato, S., Ishii, K. J., Coban, C., Hemmi, H., Yamamoto, M., Terai, K., Matsuda, M., Inoue, J.-I., Uematsu, S., et al. (2004) · Nature Immunology · doi:10.1038/ni1118 · Cited by 1,033
The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination
Kovalenko, A., Chable-Bessia, C., Cantarella, G., Israël, A., Wallach, D., & Courtois, G. (2003) · Nature · doi:10.1038/nature01802 · Cited by 1,016
Toll‐like Receptor and RIG‐1‐like Receptor Signaling
Kawai, T., & Akira, S. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1443.020 · Cited by 986
Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma
Keats, J. J., Fonseca, R., Chesi, M., Schop, R., Baker, A., Chng, W.-J., Van Wier, S., Tiedemann, R., Shi, C.-X., Sebag, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.003 · Cited by 983
Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6
Häcker, H., Redecke, V., Blagoev, B., Kratchmarova, I., Hsu, L.-C., Wang, G. G., Kamps, M. P., Raz, E., Wagner, H., Häcker, G., et al. (2006) · Nature · doi:10.1038/nature04369 · Cited by 968
CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members
Trompouki, E., Hatzivassiliou, E., Tsichritzis, T., Farmer, H., Ashworth, A., & Mosialos, G. (2003) · Nature · doi:10.1038/nature01803 · Cited by 961
Annunziata, C. M., Davis, R. E., Demchenko, Y., Bellamy, W., Gabrea, A., Zhan, F., Lenz, G., Hanamura, I., Wright, G., Xiao, W., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.004 · Cited by 952
Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response
Oganesyan, G., Saha, S. K., Guo, B., He, J. Q., Shahangian, A., Zarnegar, B., Perry, A., & Cheng, G. (2006) · Nature · doi:10.1038/nature04374 · Cited by 881
TRAF1–C5 as a Risk Locus for Rheumatoid Arthritis — A Genomewide Study
Plenge, R. M., Seielstad, M., Padyukov, L., Lee, A. T., Remmers, E. F., Ding, B., Liew, A., Khalili, H., Chandrasekaran, A., Davies, L. R. L., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073491 · Cited by 823
Yeh, W.-C., Shahinian, A., Speiser, D., Kraunus, J., Billia, F., Wakeham, A., de la Pompa, J. L., Ferrick, D., Hum, B., Iscove, N., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80391-x · Cited by 798
Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2
Alvarez, S. E., Harikumar, K. B., Hait, N. C., Allegood, J., Strub, G. M., Kim, E. Y., Maceyka, M., Jiang, H., Luo, C., Kordula, T., et al. (2010) · Nature · doi:10.1038/nature09128 · Cited by 752
Activation of innate immune antiviral responses by Nod2
Sabbah, A., Chang, T. H., Harnack, R., Frohlich, V., Tominaga, K., Dube, P. H., Xiang, Y., & Bose, S. (2009) · Nature Immunology · doi:10.1038/ni.1782 · Cited by 751
Hou, J., Wang, P., Lin, L., Liu, X., Ma, F., An, H., Wang, Z., & Cao, X. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900707 · Cited by 739
Sun, L., Deng, L., Ea, C.-K., Xia, Z.-P., & Chen, Z. J. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00236-9 · Cited by 699
The E3 Ligase TRAF6 Regulates Akt Ubiquitination and Activation
Yang, W.-L., Wang, J., Chan, C.-H., Lee, S.-W., Campos, A. D., Lamothe, B., Hur, L., Grabiner, B. C., Lin, X., Darnay, B. G., et al. (2009) · Science · doi:10.1126/science.1175065 · Cited by 674
Distinct molecular mechanism for initiating TRAF6 signalling
Ye, H., Arron, J. R., Lamothe, B., Cirilli, M., Kobayashi, T., Shevde, N. K., Segal, D., Dzivenu, O. K., Vologodskaia, M., Yim, M., et al. (2002) · Nature · doi:10.1038/nature00888 · Cited by 662
Inhibition of NF-κB Signaling by A20 Through Disruption of Ubiquitin Enzyme Complexes
Shembade, N., Ma, A., & Harhaj, E. W. (2010) · Science · doi:10.1126/science.1182364 · Cited by 643
Naito, A., Azuma, S., Tanaka, S., Miyazaki, T., Takaki, S., Takatsu, K., Nakao, K., Nakamura, K., Katsuki, M., Yamamoto, T., et al. (1999) · Genes to Cells · doi:10.1046/j.1365-2443.1999.00265.x · Cited by 635
Qian, Y., Liu, C., Hartupee, J., Altuntas, C. Z., Gulen, M. F., Jane-wit, D., Xiao, J., Lu, Y., Giltiay, N., Liu, J., et al. (2007) · Nature Immunology · doi:10.1038/ni1439 · Cited by 614 · cited 1×
“Activated NF-κB further induces the expression of IkBζ, C/EBPδ and C/EBPβ, transcription factors that work in concert with NF-κB to induce the expression of signature target genes of IL-17 [12,147,154-158].”
BackgroundVallabhapurapu, S., Matsuzawa, A., Zhang, W., Tseng, P.-H., Keats, J. J., Wang, H., Vignali, D. A. A., Bergsagel, P. L., & Karin, M. (2008) · Nature Immunology · doi:10.1038/ni.1678 · Cited by 608
Zarnegar, B. J., Wang, Y., Mahoney, D. J., Dempsey, P. W., Cheung, H. H., He, J., Shiba, T., Yang, X., Yeh, W.-C., Mak, T. W., et al. (2008) · Nature Immunology · doi:10.1038/ni.1676 · Cited by 604
Direct activation of protein kinases by unanchored polyubiquitin chains
Xia, Z.-P., Sun, L., Chen, X., Pineda, G., Jiang, X., Adhikari, A., Zeng, W., & Chen, Z. J. (2009) · Nature · doi:10.1038/nature08247 · Cited by 575
TRAF6 Mediates Smad-Independent Activation of JNK and p38 by TGF-β
Yamashita, M., Fatyol, K., Jin, C., Wang, X., Liu, Z., & Zhang, Y. E. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.09.002 · Cited by 559
The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner
Sorrentino, A., Thakur, N., Grimsby, S., Marcusson, A., von Bulow, V., Schuster, N., Zhang, S., Heldin, C.-H., & Landström, M. (2008) · Nature Cell Biology · doi:10.1038/ncb1780 · Cited by 553
Allen, I. C., Wilson, J. E., Schneider, M., Lich, J. D., Roberts, R. A., Arthur, J. C., Woodford, R.-M. T., Davis, B. K., Uronis, J. M., Herfarth, H. H., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.012 · Cited by 534
A critical role of RICK/RIP2 polyubiquitination in Nod‐induced NF‐κB activation
Hasegawa, M., Fujimoto, Y., Lucas, P. C., Nakano, H., Fukase, K., Núñez, G., & Inohara, N. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601962 · Cited by 522
Inhibitor of Apoptosis Proteins Limit RIP3 Kinase-Dependent Interleukin-1 Activation
Vince, J. E., Wong, W. W.-L., Gentle, I., Lawlor, K. E., Allam, R., O'Reilly, L., Mason, K., Gross, O., Ma, S., Guarda, G., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.012 · Cited by 491
Devergne, O., Hatzivassiliou, E., Izumi, K. M., Kaye, K. M., Kleijnen, M. F., Kieff, E., & Mosialos, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.12.7098 · Cited by 491
Expanding TRAF function: TRAF3 as a tri-faced immune regulator
Häcker, H., Tseng, P.-H., & Karin, M. (2011) · Nature Reviews Immunology · doi:10.1038/nri2998 · Cited by 471
TRAF6 and A20 Regulate Lysine 63–Linked Ubiquitination of Beclin-1 to Control TLR4-Induced Autophagy
Shi, C.-S., & Kehrl, J. H. (2010) · Science Signaling · doi:10.1126/scisignal.2000751 · Cited by 470
TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2
Li, X., Yang, Y., & Ashwell, J. D. (2002) · Nature · doi:10.1038/416345a · Cited by 452
A Deubiquitinase That Regulates Type I Interferon Production
Kayagaki, N., Phung, Q., Chan, S., Chaudhari, R., Quan, C., O'Rourke, K. M., Eby, M., Pietras, E., Cheng, G., Bazan, J. F., et al. (2007) · Science · doi:10.1126/science.1145918 · Cited by 452
Inoue, J.-I., Ishida, T., Tsukamoto, N., Kobayashi, N., Naito, A., Azuma, S., & Yamamoto, T. (2000) · Experimental Cell Research · doi:10.1006/excr.1999.4733 · Cited by 447
TLR-4, IL-1R and TNF-R signaling to NF-κB: variations on a common theme
Verstrepen, L., Bekaert, T., Chau, T.-L., Tavernier, J., Chariot, A., & Beyaert, R. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8064-8 · Cited by 440
Signal transduction by tumor necrosis factor receptors
Cabal-Hierro, L., & Lazo, P. S. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.02.006 · Cited by 436
NLR functions in plant and animal immune systems: so far and yet so close
Maekawa, T., Kufer, T. A., & Schulze-Lefert, P. (2011) · Nature Immunology · doi:10.1038/ni.2083 · Cited by 424
Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif
Saha, S. K., Pietras, E. M., He, J. Q., Kang, J. R., Liu, S., Oganesyan, G., Shahangian, A., Zarnegar, B., Shiba, T. L., Wang, Y., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601220 · Cited by 423
Dissecting negative regulation of Toll-like receptor signaling
Kondo, T., Kawai, T., & Akira, S. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.05.002 · Cited by 419
Tseng, P.-H., Matsuzawa, A., Zhang, W., Mino, T., Vignali, D. A. A., & Karin, M. (2010) · Nature Immunology · doi:10.1038/ni.1819 · Cited by 387
Genetic variation in Toll-like receptors and disease susceptibility
Netea, M. G., Wijmenga, C., & O'Neill, L. A. J. (2012) · Nature Immunology · doi:10.1038/ni.2284 · Cited by 376
The Ubiquitin Ligase XIAP Recruits LUBAC for NOD2 Signaling in Inflammation and Innate Immunity
Damgaard, R. B., Nachbur, U., Yabal, M., Wong, W. W.-L., Fiil, B. K., Kastirr, M., Rieser, E., Rickard, J. A., Bankovacki, A., Peschel, C., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.04.014 · Cited by 375
The Poxvirus Protein A52R Targets Toll-like Receptor Signaling Complexes to Suppress Host Defense
Harte, M. T., Haga, I. R., Maloney, G., Gray, P., Reading, P. C., Bartlett, N. W., Smith, G. L., Bowie, A., & O'Neill, L. A. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021652 · Cited by 370
Allen, I. C., Moore, C. B., Schneider, M., Lei, Y., Davis, B. K., Scull, M. A., Gris, D., Roney, K. E., Zimmermann, A. G., Bowzard, J. B., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.026 · Cited by 364
Regulation of the Antimicrobial Response by NLR Proteins
Elinav, E., Strowig, T., Henao-Mejia, J., & Flavell, R. A. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.007 · Cited by 361
Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor
Chang, S. H., Park, H., & Dong, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c600256200 · Cited by 356 · cited 1×
“Activated NF-κB further induces the expression of IkBζ, C/EBPδ and C/EBPβ, transcription factors that work in concert with NF-κB to induce the expression of signature target genes of IL-17 [12,147,154-158].”
BackgroundThe TNF-receptor-associated factor family
Wajant, H., Henkler, F., & Scheurich, P. (2001) · Cellular Signalling · doi:10.1016/s0898-6568(01)00160-7 · Cited by 353
Schwandner, R., Yamaguchi, K., & Cao, Z. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.7.1233 · Cited by 349 · cited 1×
“Activated NF-κB further induces the expression of IkBζ, C/EBPδ and C/EBPβ, transcription factors that work in concert with NF-κB to induce the expression of signature target genes of IL-17 [12,147,154-158].”
BackgroundPérez de Diego, R., Sancho-Shimizu, V., Lorenzo, L., Puel, A., Plancoulaine, S., Picard, C., Herman, M., Cardon, A., Durandy, A., Bustamante, J., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.08.014 · Cited by 349
He, B., Santamaria, R., Xu, W., Cols, M., Chen, K., Puga, I., Shan, M., Xiong, H., Bussel, J. B., Chiu, A., et al. (2010) · Nature Immunology · doi:10.1038/ni.1914 · Cited by 349
TRAF5, an Activator of NF-κB and Putative Signal Transducer for the Lymphotoxin-β Receptor
Nakano, H., Oshima, H., Chung, W., Williams-Abbott, L., Ware, C. F., Yagita, H., & Okumura, K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.14661 · Cited by 346
Bertrand, M. J. M., Doiron, K., Labbé, K., Korneluk, R. G., Barker, P. A., & Saleh, M. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.011 · Cited by 340
RIG‐I‐like receptors: cytoplasmic sensors for non‐self RNA
Kato, H., Takahasi, K., & Fujita, T. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01052.x · Cited by 339
Muppidi, J. R., Tschopp, J., & Siegel, R. M. (2004) · Immunity · doi:10.1016/j.immuni.2004.10.001 · Cited by 338
Ishida, T. K., Tojo, T., Aoki, T., Kobayashi, N., Ohishi, T., Watanabe, T., Yamamoto, T., & Inoue, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9437 · Cited by 336
Schneider, M., Zimmermann, A. G., Roberts, R. A., Zhang, L., Swanson, K. V., Wen, H., Davis, B. K., Allen, I. C., Holl, E. K., Ye, Z., et al. (2012) · Nature Immunology · doi:10.1038/ni.2378 · Cited by 335
The NEMO adaptor bridges the nuclear factor-κB and interferon regulatory factor signaling pathways
Zhao, T., Yang, L., Sun, Q., Arguello, M., Ballard, D. W., Hiscott, J., & Lin, R. (2007) · Nature Immunology · doi:10.1038/ni1465 · Cited by 318
Toll-like receptor signaling in cell proliferation and survival
Li, X., Jiang, S., & Tapping, R. I. (2010) · Cytokine · doi:10.1016/j.cyto.2009.08.010 · Cited by 309
Choi, Y.-S., Choi, H.-J., Min, J.-K., Pyun, B.-J., Maeng, Y.-S., Park, H., Kim, J., Kim, Y.-M., & Kwon, Y.-G. (2009) · Blood · doi:10.1182/blood-2009-02-203372 · Cited by 302
MCP-induced protein 1 deubiquitinates TRAF proteins and negatively regulates JNK and NF-κB signaling
Liang, J., Saad, Y., Lei, T., Wang, J., Qi, D., Yang, Q., Kolattukudy, P. E., & Fu, M. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092641 · Cited by 297
Classical and/or alternative NF-κB pathway activation in multiple myeloma
Demchenko, Y. N., Glebov, O. K., Zingone, A., Keats, J. J., Bergsagel, P. L., & Kuehl, W. M. (2010) · Blood · doi:10.1182/blood-2009-09-243535 · Cited by 288
Signaling by the tumor necrosis factor receptor superfamily in B‐cell biology and disease
Rickert, R. C., Jellusova, J., & Miletic, A. V. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01067.x · Cited by 285
Recent advances in the IL-17 cytokine family
Gaffen, S. L. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.07.006 · Cited by 283
Hinz, M., Stilmann, M., Arslan, S. Ç., Khanna, K. K., Dittmar, G., & Scheidereit, C. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.008 · Cited by 280
Viral apoptosis is induced by IRF‐3‐mediated activation of Bax
Chattopadhyay, S., Marques, J. T., Yamashita, M., Peters, K. L., Smith, K., Desai, A., Williams, B. R. G., & Sen, G. C. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.50 · Cited by 277
NLRX1 Negatively Regulates TLR-Induced NF-κB Signaling by Targeting TRAF6 and IKK
Xia, X., Cui, J., Wang, H. Y., Zhu, L., Matsueda, S., Wang, Q., Yang, X., Hong, J., Songyang, Z., Chen, Z. J., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.022 · Cited by 273
Siu, K.-L., Kok, K.-H., Ng, M.-H. J., Poon, V. K. M., Yuen, K.-Y., Zheng, B.-J., & Jin, D.-Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.008227 · Cited by 272
TRAF6 Is a Critical Factor for Dendritic Cell Maturation and Development
Kobayashi, T., Walsh, P. T., Walsh, M. C., Speirs, K. M., Chiffoleau, E., King, C. G., Hancock, W. W., Caamano, J. H., Hunter, C. A., Scott, P., et al. (2003) · Immunity · doi:10.1016/s1074-7613(03)00230-9 · Cited by 267
Watanabe, T., Asano, N., Fichtner-Feigl, S., Gorelick, P. L., Tsuji, Y., Matsumoto, Y., Chiba, T., Fuss, I. J., Kitani, A., & Strober, W. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39481 · Cited by 262
Shen, F., & Gaffen, S. L. (2008) · Cytokine · doi:10.1016/j.cyto.2007.11.013 · Cited by 256
Akiba, H., Nakano, H., Nishinaka, S., Shindo, M., Kobata, T., Atsuta, M., Morimoto, C., Ware, C. F., Malinin, N. L., Wallach, D., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.13353 · Cited by 250
Gardam, S., Sierro, F., Basten, A., Mackay, F., & Brink, R. (2008) · Immunity · doi:10.1016/j.immuni.2008.01.009 · Cited by 248
Zhang, J., Stirling, B., Temmerman, S. T., Ma, C. A., Fuss, I. J., Derry, J. M. J., & Jain, A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28746 · Cited by 245
Targeted Disruption of TRAF3 Leads to Postnatal Lethality and Defective T-Dependent Immune Responses
Xu, Y., Cheng, G., & Baltimore, D. (1996) · Immunity · doi:10.1016/s1074-7613(00)80497-5 · Cited by 243
Vince, J. E., Pantaki, D., Feltham, R., Mace, P. D., Cordier, S. M., Schmukle, A. C., Davidson, A. J., Callus, B. A., Wong, W. W.-L., Gentle, I. E., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.072256 · Cited by 241
Hatzoglou, A., Roussel, J., Bourgeade, M.-F., Rogier, E., Madry, C., Inoue, J., Devergne, O., & Tsapis, A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.3.1322 · Cited by 240
OX40 signaling favors the induction of TH9 cells and airway inflammation
Xiao, X., Balasubramanian, S., Liu, W., Chu, X., Wang, H., Taparowsky, E. J., Fu, Y.-X., Choi, Y., Walsh, M. C., & Li, X. C. (2012) · Nature Immunology · doi:10.1038/ni.2390 · Cited by 237
Conze, D. B., Wu, C.-J., Thomas, J. A., Landstrom, A., & Ashwell, J. D. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.02098-07 · Cited by 237
Vince, J. E., Chau, D., Callus, B., Wong, W. W.-L., Hawkins, C. J., Schneider, P., McKinlay, M., Benetatos, C. A., Condon, S. M., Chunduru, S. K., et al. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200801010 · Cited by 236
IL-17 family member cytokines: Regulation and function in innate immunity
Reynolds, J. M., Angkasekwinai, P., & Dong, C. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.10.002 · Cited by 235
Saitoh, T., Satoh, T., Yamamoto, N., Uematsu, S., Takeuchi, O., Kawai, T., & Akira, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.010 · Cited by 234
Sun, D., Novotny, M., Bulek, K., Liu, C., Li, X., & Hamilton, T. (2011) · Nature Immunology · doi:10.1038/ni.2081 · Cited by 232
Signaling of interleukin-17 family cytokines in immunity and inflammation
Chang, S. H., & Dong, C. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2010.11.022 · Cited by 229
Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice
Paul, P. K., Gupta, S. K., Bhatnagar, S., Panguluri, S. K., Darnay, B. G., Choi, Y., & Kumar, A. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201006098 · Cited by 227
Act1, a U-box E3 Ubiquitin Ligase for IL-17 Signaling
Liu, C., Qian, W., Qian, Y., Giltiay, N. V., Lu, Y., Swaidani, S., Misra, S., Deng, L., Chen, Z. J., & Li, X. (2009) · Science Signaling · doi:10.1126/scisignal.2000382 · Cited by 224 · cited 1×
“For example, Act1-mediated K63-linked ubiquitination of TRAF6 recruits TAB2/3-TAK1 and NEMO to activate NF-κB in IL-17R signaling [201], while cIAP1/2catalyzed K63-linked ubiquitination of TRAF3 recruits TBK1 and IKKε to induce type I IFN production in RIG-I signaling [144].”
BackgroundIL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease
Zepp, J., Wu, L., & Li, X. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.02.007 · Cited by 224
RIG-I-like receptors: Sensing and responding to RNA virus infection
Nakhaei, P., Genin, P., Civas, A., & Hiscott, J. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.05.001 · Cited by 223
Xie, P., Stunz, L. L., Larison, K. D., Yang, B., & Bishop, G. A. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.012 · Cited by 217
Self-citationEssential Cytoplasmic Translocation of a Cytokine Receptor–Assembled Signaling Complex
Matsuzawa, A., Tseng, P.-H., Vallabhapurapu, S., Luo, J.-L., Zhang, W., Wang, H., Vignali, D. A. A., Gallagher, E., & Karin, M. (2008) · Science · doi:10.1126/science.1157340 · Cited by 217
Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF‐κB
Habelhah, H., Takahashi, S., Cho, S., Kadoya, T., Watanabe, T., & Ronai, Z. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600044 · Cited by 207
Zhong, B., Liu, X., Wang, X., Chang, S. H., Liu, X., Wang, A., Reynolds, J. M., & Dong, C. (2012) · Nature Immunology · doi:10.1038/ni.2427 · Cited by 206 · cited 1×
“Notably, A20 and MCPIP1 mice spontaneously develop severe inflammatory syndrome [219,220], while CYLD and Usp25 mice are more susceptible to inflammation [204,221].”
BackgroundTRAF6 is a T cell–intrinsic negative regulator required for the maintenance of immune homeostasis
King, C. G., Kobayashi, T., Cejas, P. J., Kim, T., Yoon, K., Kim, G. K., Chiffoleau, E., Hickman, S. P., Walsh, P. T., Turka, L. A., et al. (2006) · Nature Medicine · doi:10.1038/nm1449 · Cited by 206
NOD-like receptors and the innate immune system: Coping with danger, damage and death
Kersse, K., Bertrand, M. J. M., Lamkanfi, M., & Vandenabeele, P. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2011.09.003 · Cited by 201
TRAF‐Mediated TNFR‐Family Signaling
Ha, H., Han, D., & Choi, Y. (2009) · Current Protocols in Immunology · doi:10.1002/0471142735.im1109ds87 · Cited by 201
Kawamata, S., Hori, T., Imura, A., Takaori-Kondo, A., & Uchiyama, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5808 · Cited by 200
RIG-I like receptors and their signaling crosstalk in the regulation of antiviral immunity
Ramos, H. J., & Gale, M. (2011) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.04.004 · Cited by 200
Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: Key regulators of innate immunity
Barral, P. M., Sarkar, D., Su, Z.-Z., Barber, G. N., DeSalle, R., Racaniello, V. R., & Fisher, P. B. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.06.012 · Cited by 200
Ryzhakov, G., & Randow, F. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601743 · Cited by 197
Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice
Jin, W., Chang, M., Paul, E. M., Babu, G., Lee, A. J., Reiley, W., Wright, A., Zhang, M., You, J., & Sun, S.-C. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34257 · Cited by 195
TRAF Proteins in CD40 Signaling
Bishop, G. A., Moore, C. R., Xie, P., Stunz, L. L., & Kraus, Z. J. (2007) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-70630-6_11 · Cited by 194
Self-citationVarfolomeev, E., Goncharov, T., Maecker, H., Zobel, K., Kömüves, L. G., Deshayes, K., & Vucic, D. (2012) · Science Signaling · doi:10.1126/scisignal.2001878 · Cited by 193
BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway
Craxton, A., Draves, K. E., Gruppi, A., & Clark, E. A. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051283 · Cited by 193
Bulek, K., Liu, C., Swaidani, S., Wang, L., Page, R. C., Gulen, M. F., Herjan, T., Abbadi, A., Qian, W., Sun, D., et al. (2011) · Nature Immunology · doi:10.1038/ni.2080 · Cited by 192
Yu, M., & Levine, S. J. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2011.02.001 · Cited by 190
Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma
Rossi, D., Deaglio, S., Dominguez-Sola, D., Rasi, S., Vaisitti, T., Agostinelli, C., Spina, V., Bruscaggin, A., Monti, S., Cerri, M., et al. (2011) · Blood · doi:10.1182/blood-2011-06-359166 · Cited by 189
Key Role of Ubc5 and Lysine-63 Polyubiquitination in Viral Activation of IRF3
Zeng, W., Xu, M., Liu, S., Sun, L., & Chen, Z. J. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.037 · Cited by 188
Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation
Nakano, H., Sakon, S., Koseki, H., Takemori, T., Tada, K., Matsumoto, M., Munechika, E., Sakai, T., Shirasawa, T., Akiba, H., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9803 · Cited by 188
Wang, D., Fang, L., Li, P., Sun, L., Fan, J., Zhang, Q., Luo, R., Liu, X., Li, K., Chen, H., et al. (2011) · Journal of Virology · doi:10.1128/jvi.02589-10 · Cited by 186
TRAF7 Potentiates MEKK3-induced AP1 and CHOP Activation and Induces Apoptosis
Xu, L.-G., Li, L.-Y., & Shu, H.-B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400063200 · Cited by 183
Coordinated Regulation of Toll-Like Receptor and NOD2 Signaling by K63-Linked Polyubiquitin Chains
Abbott, D. W., Yang, Y., Hutti, J. E., Madhavarapu, S., Kelliher, M. A., & Cantley, L. C. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00270-07 · Cited by 183
TRAF6 ubiquitinates TGFβ type I receptor to promote its cleavage and nuclear translocation in cancer
Mu, Y., Sundar, R., Thakur, N., Ekman, M., Gudey, S. K., Yakymovych, M., Hermansson, A., Dimitriou, H., Bengoechea-Alonso, M. T., Ericsson, J., et al. (2011) · Nature Communications · doi:10.1038/ncomms1332 · Cited by 182
Li, S., Zheng, H., Mao, A.-P., Zhong, B., Li, Y., Liu, Y., Gao, Y., Ran, Y., Tien, P., & Shu, H.-B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.074971 · Cited by 181
TRAF1 Is a Negative Regulator of TNF Signaling
Tsitsikov, E. N., Laouini, D., Dunn, I. F., Sannikova, T. Y., Davidson, L., Alt, F. W., & Geha, R. S. (2001) · Immunity · doi:10.1016/s1074-7613(01)00207-2 · Cited by 180
ATAR, a Novel Tumor Necrosis Factor Receptor Family Member, Signals through TRAF2 and TRAF5
Hsu, H., Solovyev, I., Colombero, A., Elliott, R., Kelley, M., & Boyle, W. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.21.13471 · Cited by 180
TRAF6 -deficient mice display hypohidrotic ectodermal dysplasia
Naito, A., Yoshida, H., Nishioka, E., Satoh, M., Azuma, S., Yamamoto, T., Nishikawa, S.-I., & Inoue, J.-I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132636999 · Cited by 178
Deciphering the complexity of Toll-like receptor signaling
Ostuni, R., Zanoni, I., & Granucci, F. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0464-x · Cited by 176
VanArsdale, T. L., VanArsdale, S. L., Force, W. R., Walter, B. N., Mosialos, G., Kieff, E., Reed, J. C., & Ware, C. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2460 · Cited by 175
Nakhaei, P., Mesplede, T., Solis, M., Sun, Q., Zhao, T., Yang, L., Chuang, T.-H., Ware, C. F., Lin, R., & Hiscott, J. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000650 · Cited by 174
TRAF6 is an amplified oncogene bridging the RAS and NF-κB pathways in human lung cancer
Starczynowski, D. T., Lockwood, W. W., Deléhouzée, S., Chari, R., Wegrzyn, J., Fuller, M., Tsao, M.-S., Lam, S., Gazdar, A. F., Lam, W. L., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci58818 · Cited by 173
Paik, J. H., Jang, J.-Y., Jeon, Y. K., Kim, W. Y., Kim, T. M., Heo, D. S., & Kim, C.-W. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0494 · Cited by 173
TAX1BP1 and A20 Inhibit Antiviral Signaling by Targeting TBK1-IKKi Kinases
Parvatiyar, K., Barber, G. N., & Harhaj, E. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.109819 · Cited by 170
Labbé, K., McIntire, C. R., Doiron, K., Leblanc, P. M., & Saleh, M. (2011) · Immunity · doi:10.1016/j.immuni.2011.10.016 · Cited by 170
IL-17F: Regulation, signaling and function in inflammation
Chang, S. H., & Dong, C. (2009) · Cytokine · doi:10.1016/j.cyto.2008.12.024 · Cited by 169
Paul, P. K., Bhatnagar, S., Mishra, V. K., Srivastava, S., Darnay, B. G., Choi, Y., & Kumar, A. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06351-11 · Cited by 169
Fan, Y., Yu, Y., Shi, Y., Sun, W., Xie, M., Ge, N., Mao, R., Chang, A., Xu, G., Schneider, M. D., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.076976 · Cited by 168
Paz, S., Vilasco, M., Werden, S. J., Arguello, M., Joseph-Pillai, D., Zhao, T., Nguyên, T. L.-A., Sun, Q., MEURS, E. F., Lin, R., et al. (2011) · Cell Research · doi:10.1038/cr.2011.2 · Cited by 168
Sabbagh, L., Pulle, G., Liu, Y., Tsitsikov, E. N., & Watts, T. H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.12.8093 · Cited by 167
He, W., Wang, Q., Xu, J., Xu, X., Padilla, M. T., Ren, G., Gou, X., & Lin, Y. (2012) · Autophagy · doi:10.4161/auto.22145 · Cited by 165
Rescue of TRAF3-null mice by p100 NF-κB deficiency
He, J. Q., Zarnegar, B., Oganesyan, G., Saha, S. K., Yamazaki, S., Doyle, S. E., Dempsey, P. W., & Cheng, G. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061166 · Cited by 165
TRAF ‐Mediated TNFR ‐Family Signaling
Arron, J. R., Walsh, M. C., & Choi, Y. (2002) · Current Protocols in Immunology · doi:10.1002/0471142735.im1109ds51 · Cited by 164
Carpenter, S., & O'Neill, L. A. J. (2009) · Biochemical Journal · doi:10.1042/bj20090616 · Cited by 164
Braggio, E., Keats, J. J., Leleu, X. P., Wier, S. V., Jimenez-Zepeda, V. H., Valdez, R., Schop, R. F. J., Price-Troska, T. L., Henderson, K. J., Sacco, A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3701 · Cited by 163
Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma
Cerhan, J. R., Ansell, S. M., Fredericksen, Z. S., Kay, N. E., Liebow, M., Call, T. G., Dogan, A., Cunningham, J. M., Wang, A. H., Liu-Mares, W., et al. (2007) · Blood · doi:10.1182/blood-2007-05-088682 · Cited by 161
A new eye on NLR proteins: focused on clarity or diffused by complexity?
Bonardi, V., Cherkis, K., Nishimura, M. T., & Dangl, J. L. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.12.006 · Cited by 161
B cell maturation protein is a receptor for the tumor necrosis factor family member TALL-1
Shu, H., & Johnson, H. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160213497 · Cited by 160
Requirement for TRAF3 in Signaling by LMP1 But Not CD40 in B Lymphocytes
Xie, P., Hostager, B. S., & Bishop, G. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031255 · Cited by 159
Self-citationZhu, S., Pan, W. Q., Shi, P., Gao, H., Zhao, F., Song, X., Liu, Y., Zhao, L., Li, X., Shi, Y., et al. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20100703 · Cited by 157
The IL‐17 pathway as a major therapeutic target in autoimmune diseases
Hu, Y., Shen, F., Crellin, N. K., & Ouyang, W. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05825.x · Cited by 156
Brown, K. D., Hostager, B. S., & Bishop, G. A. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.8.943 · Cited by 156
Xiao, N., Li, H., Luo, J., Wang, R., Chen, H., Chen, J., & Wang, P. (2011) · Biochemical Journal · doi:10.1042/bj20111358 · Cited by 155
IL-17-induced NF-κB Activation via CIKS/Act1
Sønder, S. U., Saret, S., Tang, W., Sturdevant, D. E., Porcella, S. F., & Siebenlist, U. K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.199547 · Cited by 149
Eitel, J., Meixenberger, K., Suttorp, N., & Opitz, B. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-05-0323 · Cited by 148
Kojima, T., Morikawa, Y., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Senba, E., & Kitamura, T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002691200 · Cited by 146
NLR-mediated control of inflammasome assembly in the host response against bacterial pathogens
Brodsky, I. E., & Monack, D. M. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.05.007 · Cited by 144
Arron, J. R., Pewzner‐Jung, Y., Walsh, M. C., Kobayashi, T., & Choi, Y. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020774 · Cited by 144
TNFR-Associated Factor Family Protein Expression in Normal Tissues and Lymphoid Malignancies
Zapata, J. M., Krajewska, M., Krajewski, S., Kitada, S., Welsh, K., Monks, A. P., McCloskey, N., Gordon, J., Kipps, T. J., Gascoyne, R. D., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.9.5084 · Cited by 144
TRAF6 is a critical signal transducer in IL-33 signaling pathway
Funakoshi‐Tago, M., Tago, K., Hayakawa, M., Tominaga, S., Ohshio, T., Sonoda, Y., & Kasahara, T. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.05.013 · Cited by 141
Mao, A., Li, S., Zhong, B., Li, Y., Yan, J., Li, Q., Teng, C., & Shu, H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.071043 · Cited by 140
YopJ targets TRAF proteins to inhibit TLR-mediated NF-?B, MAPK and IRF3 signal transduction
Sweet, C. R., Conlon, J. E., Golenbock, D. T., Goguen, J. D., & Silverman, N. S. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00990.x · Cited by 139
Konno, H., Yamamoto, T., Yamazaki, K., Gohda, J., Akiyama, T., Semba, K., Goto, H., Kato, A., Yujiri, T., Imai, T., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005674 · Cited by 137
Toll-like receptor signaling in the lysosomal pathways
Sanjuan, M. A., Milasta, S., & Green, D. R. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00732.x · Cited by 137
IL-17 Receptor Signaling Inhibits C/EBPβ by Sequential Phosphorylation of the Regulatory 2 Domain
Shen, F., Li, N., Gade, P., Kalvakolanu, D. V., Weibley, T., Doble, B. W., Woodgett, J. R., Wood, T. D., & Gaffen, S. L. (2009) · Science Signaling · doi:10.1126/scisignal.2000066 · Cited by 135
Balkhi, M. Y., Fitzgerald, K. A., & Pitha, P. M. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00662-08 · Cited by 129
Autophagy in regulation of Toll-like receptor signaling
Into, T., Inomata, M., Takayama, E., & Takigawa, T. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.01.020 · Cited by 128
TIR-containing adaptors in Toll-like receptor signalling
Jenkins, K. A., & Mansell, A. S. (2009) · Cytokine · doi:10.1016/j.cyto.2009.01.009 · Cited by 127
Mikkelsen, S. S., Jensen, S. B., Chiliveru, S., Melchjorsen, J., Julkunen, I., Gaestel, M., Arthur, J. S. C., Flavell, R. A., Ghosh, S., & Paludan, S. R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807272200 · Cited by 127
Regulation of TNFRSF and innate immune signalling complexes by TRAFs and cIAPs
Silke, J., & Brink, R. A. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.114 · Cited by 125
Hildebrand, J. M., Luo, Z., Manske, M. K., Price-Troska, T. L., Ziesmer, S. C., Lin, W., Hostager, B. S., Slager, S. L., Witzig, T. E., Ansell, S. M., et al. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20100857 · Cited by 125
Belgnaoui, S. M., Paz, S., Samuel, S., Goulet, M.-L., Sun, Q., Kikkert, M., Iwaï, K., Đikić, I., Hiscott, J. B., & Lin, R. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.06.009 · Cited by 124
Lamothe, B., Campos, A. D., Webster, W. K., Gopinathan, A., Hur, L., & Darnay, B. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802749200 · Cited by 123
T‐cell intrinsic effects of GITR and 4‐1BB during viral infection and cancer immunotherapy
Snell, L. M., Lin, G. H. Y., McPherson, A. J., Moraes, T. J., & Watts, T. H. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01063.x · Cited by 122
The essential roles of Toll-like receptor signaling pathways in sterile inflammatory diseases
Lin, Q., Li, M., Fang, D., Fang, J., & Su, S. B. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.04.026 · Cited by 121
The regulation of TNF signalling: what a tangled web we weave
Silke, J. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.08.002 · Cited by 120
Yoboua, F., Martel, A., Duval, A., Mukawera, E., & Grandvaux, N. (2010) · Journal of Virology · doi:10.1128/jvi.00142-10 · Cited by 120
Structural Basis for the Lack of E2 Interaction in the RING Domain of TRAF2
Yin, Q., Lamothe, B., Darnay, B. G., & Wu, H. (2009) · Biochemistry · doi:10.1021/bi901462e · Cited by 119
PKC Phosphorylation of TRAF2 Mediates IKKα/β Recruitment and K63-Linked Polyubiquitination
Li, S., Wang, L., & Dorf, M. E. (2009) · Molecular Cell · doi:10.1016/j.molcel.2008.11.023 · Cited by 118
Ning, S., Campos, A. R., Darnay, B. G., Bentz, G. L., & Pagano, J. S. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00785-08 · Cited by 116
Mechanism of inhibiting type I interferon induction by hepatitis B virus X protein
Jiang, J., & Tang, H. (2010) · Protein & Cell · doi:10.1007/s13238-010-0141-8 · Cited by 112
Emerging Role of Ubiquitination in Antiviral RIG-I Signaling
Maelfait, J., & Beyaert, R. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05012-11 · Cited by 111
Hildebrand, J. M., Yi, Z., Buchta, C. M., Poovassery, J., Stunz, L. L., & Bishop, G. A. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01055.x · Cited by 110
TRAF6 and MEKK1 Play a Pivotal Role in the RIG-I-like Helicase Antiviral Pathway
Yoshida, R., Takaesu, G., Yoshida, H., Okamoto, F., Yoshioka, T., Choi, Y., Akira, S., Kawai, T., Yoshimura, A., & Kobayashi, T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806576200 · Cited by 110
TRAF4 acts as a silencer in TLR-mediated signaling through the association with TRAF6 and TRIF
Takeshita, F., Ishii, K. J., Kobiyama, K., Kojima, Y., Coban, C., Sasaki, S., Ishii, N., Klinman, D. M., Okuda, K., Akira, S., et al. (2005) · European Journal of Immunology · doi:10.1002/eji.200526151 · Cited by 110
Régnier, C. H., Masson, R., Kedinger, V., Textoris, J., Stoll, I., Chenard, M., Dierich, A., Tomasetto, C., & Rio, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052124799 · Cited by 109
Wu, C.-J., Conze, D. B., Li, X., Ying, S., Hanover, J. A., & Ashwell, J. D. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600649 · Cited by 108
Gardam, S., Turner, V. M., Anderton, H., Limaye, S., Basten, A., Köentgen, F., Vaux, D. L., Silke, J., & Brink, R. A. (2011) · Blood · doi:10.1182/blood-2010-10-312793 · Cited by 108
Negative regulation of Toll-like receptor signaling pathway
Wang, J., Hu, Y., Deng, W. W., & Sun, B. (2009) · Microbes and Infection · doi:10.1016/j.micinf.2008.12.011 · Cited by 108
Two distinct amplified regions at 17q11-q21 involved in human primary breast cancer.
Bièche, I., Tomasetto, C., Régnier, C. H., Moog‐Lutz, C., Rio, M. C., & Lidereau, R. (1996) · PubMed · Cited by 106
Alff, P. J., Sen, N., Gorbunova, E. E., Gavrilovskaya, I. N., & Mackow, E. R. (2008) · Journal of Virology · doi:10.1128/jvi.00290-08 · Cited by 104
Sinha, S. K., Zachariah, S., Quiñones, H. I., Shindo, M., & Chaudhary, P. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207923200 · Cited by 103
TNF Receptor-Associated Factor 3 Is Required for T Cell-Mediated Immunity and TCR/CD28 Signaling
Xie, P., Kraus, Z., Stunz, L. L., Liu, Y., & Bishop, G. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000290 · Cited by 102
Self-citationSasai, M., Tatematsu, M., Oshiumi, H., Funami, K., Matsumoto, M., Hatakeyama, S., & Seya, T. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2009.12.002 · Cited by 102
Wicovsky, A., Henkler, F., Salzmann, S., Scheurich, P., Kneitz, C., & Wajant, H. (2009) · Oncogene · doi:10.1038/onc.2009.29 · Cited by 99
Zucchelli, S., Codrich, M., Marcuzzi, F., Pinto, M., Vilotti, S., Biagioli, M., Ferrer, I., & Gustincich, S. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq290 · Cited by 99
Yasunaga, J., Lin, F. C., Lu, X., & Jeang, K.-T. (2011) · Journal of Virology · doi:10.1128/jvi.00079-11 · Cited by 98
Opposing Roles for TRAF1 in the Alternative versus Classical NF-κB Pathway in T Cells
McPherson, A. J., Snell, L. M., Mak, T. W., & Watts, T. H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.350538 · Cited by 98
Herpesvirus tegument protein activates NF-κB signaling through the TRAF6 adaptor protein
Liu, X., Fitzgerald, K. A., Kurt‐Jones, E. A., Finberg, R. W., & Knipe, D. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801617105 · Cited by 96
Nod-like receptors: sentinels at host membranes
Philpott, D. J., & Girardin, S. E. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.04.010 · Cited by 96
TWEAK and TRAF6 regulate skeletal muscle atrophy
Kumar, A., Bhatnagar, S., & Paul, P. K. (2012) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e328351c3fc · Cited by 95
Cited by
The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J. (2014) · Nature reviews. Immunology · doi:10.1038/nri3707 · Cited by 1,585
Walsh, M. C., Lee, J., & Choi, Y. (2015) · Immunological Reviews · doi:10.1111/imr.12302 · Cited by 438
TNFR1 and TNFR2 in the Control of the Life and Death Balance of Macrophages
Wajant, H., & Siegmund, D. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00091 · Cited by 388
Shi, J.-H., & Sun, S.-C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01849 · Cited by 327
Structural principles of tumor necrosis factor superfamily signaling
Vanamee, É. S., & Faustman, D. L. (2018) · Science Signaling · doi:10.1126/scisignal.aao4910 · Cited by 280
Metadata
- Authors
- Xie, P.
- Venue
- Journal of Molecular Signaling
- Publisher
- Journal of Molecular Signaling
- Published
- 2013-06-13
- Volume
- 8
- Issue
- 1
- Pages
- 7
- ISSN
- 1750-2187 (ISSN-L)
- OpenAlex
- W2155763709
- Cited by
- 466
- References
- 321
- FWCI
- 8.59
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.